Exploratory, Phase II Controlled Trial of Shiunko Ointment Local Application Twice a Day for 4 Weeks in Ethiopian Patients with Localized Cutaneous Leishmaniasis

Table 2

The proportions of patients with satisfactory treatment response (complete cure and/or partial response) and treatment failure with lesion ulceration in Shiunko and placebo ( and 8 cases, resp.) groups (significantly different by Chi-square test, ).

	Shiunko; (%)	Placebo; (%)
Cure	3 (75%)	3 (38%)
Partial response	1 (25%)	1 (13%)
Failure	0 (0%)	4 (49%)
Total	4	8